Blast Transformation of Chronic Myeloid Leukemia Driven by Acquisition of t(8;21)(q22;q22)/<i>RUNX1::RUNX1T1</i>: Selecting Optimal Treatment Based on Clinical and Molecular Findings

The advent of tyrosine kinase inhibitors (TKIs) has changed the natural history of chronic myeloid leukemia (CML), and the transformation from the chronic phase to the blast phase (BP) is currently an uncommon situation. However, it is one of the major remaining challenges in the management of this...

Полное описание

Библиографические подробности

Главные авторы:	Adolfo Fernández-Sánchez, Alberto Hernández-Sánchez, Cristina De Ramón, María-Carmen Chillón, María Belén Vidriales, Mónica Baile-González, Cristina-Teresa Fuentes-Morales, Magdalena Sierra-Pacho, Lucía López-Corral, Fermín Sánchez-Guijo
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2024-10-01
Серии:	Biomedicines
Предметы:	chronic myeloid leukemia blast phase core binding factor rearrangement T315I mutation
Online-ссылка:	https://www.mdpi.com/2227-9059/12/10/2339
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!